compounded semaglutide or tirzepatide vs. for Weight Loss VivioMD GLP-1 Program Overview 2026:

No in-person visit is required

However, in our mouse models, we utilized diabetic models and aging models, which helps address this concern

0% of patients receiving placebo

Ozempic (semaglutide) : approved for type 2 diabetes Wegovy (semaglutide) : approved for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with weight-related comorbidities Mounjaro (tirzepatide) : approved for type 2 diabetes Zepbound (tirzepatide) : approved for chronic weight management under the same criteria as Wegovy If you dont have diabetes, the weight-management brands (Wegovy, Zepbound) are what your doctor would prescribe, assuming you meet the criteria

Your vial should maintain its red or pink color throughout this period

Following a healthy meal plan will help you manage your blood sugar and meet weight loss goals